skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ClinicalKey remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Treatment of multiple sclerosis with Anti-CD20 antibodies
Treatment of multiple sclerosis with Anti-CD20 antibodies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of multiple sclerosis with Anti-CD20 antibodies

Barun, Barbara ; Bar-Or, Amit

Clinical immunology (Orlando, Fla.), 2012-01, Vol.142 (1), p.31-37 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Interleukin-17 and innate immunity in infections and chronic inflammation
Interleukin-17 and innate immunity in infections and chronic inflammation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interleukin-17 and innate immunity in infections and chronic inflammation

Isailovic, Natasa ; Daigo, Kenji ; Mantovani, Alberto ; Selmi, Carlo

Journal of autoimmunity, 2015-06, Vol.60, p.1-11 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab

Yanai, Henit ; Lichtenstein, Lev ; Assa, Amit ; Mazor, Yoav ; Weiss, Batia ; Levine, Arie ; Ron, Yulia ; Kopylov, Uri ; Bujanover, Yoram ; Rosenbach, Yoram ; Ungar, Bella ; Eliakim, Rami ; Chowers, Yehuda ; Shamir, Raanan ; Fraser, Gerald ; Dotan, Iris ; Ben-Horin, Shomron

Clinical gastroenterology and hepatology, 2015-03, Vol.13 (3), p.522-530.e2 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Krueger, James G., MD ; Fretzin, Scott, MD ; Suárez-Fariñas, Mayte, PhD ; Haslett, Patrick A., MB, BS ; Phipps, Krista M ; Cameron, Gregory S., PhD ; McColm, Juliet, MD ; Katcherian, Artemis ; Cueto, Inna ; White, Traci ; Banerjee, Subhashis, MD ; Hoffman, Robert W., DO

Journal of allergy and clinical immunology, 2012-07, Vol.130 (1), p.145-154.e9 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
5
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

Eigentler, Thomas K ; Hassel, Jessica C ; Berking, Carola ; Aberle, Jens ; Bachmann, Oliver ; Grünwald, Viktor ; Kähler, Katharina C ; Loquai, Carmen ; Reinmuth, Niels ; Steins, Martin ; Zimmer, Lisa ; Sendl, Anna ; Gutzmer, Ralf

Cancer treatment reviews, 2016-04, Vol.45, p.7-18 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera
Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera

Lee, Joseph ; Naoe, Youichi ; Bang, Uikyu ; Nakagama, Yu ; Saito, Akatsuki ; Kido, Yasutoshi ; Hotta, Akitsu

Virology (New York, N.Y.), 2024-07, Vol.595, p.110067-110067, Article 110067 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Antibacterial monoclonal antibodies: the next generation?
Antibacterial monoclonal antibodies: the next generation?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibacterial monoclonal antibodies: the next generation?

DiGiandomenico, Antonio ; Sellman, Bret R

Current opinion in microbiology, 2015-10, Vol.27, p.78-85 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation

MacGlashan, Donald W., MD, PhD ; Saini, Sarbjit S., MD

Journal of allergy and clinical immunology, 2013-10, Vol.132 (4), p.906-911.e4 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
9
Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101
Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101
Material Type:
Artigo 		Adicionar ao Meu Espaço

Unexpected cross-reactivity of anti-cathepsin B antibodies leads to uncertainties regarding the mechanism of action of anti-CD20 monoclonal antibody GA101

Chien, Wei Wen ; Niogret, Charlène ; Jugé, Romain ; Lionnard, Loïc ; Cornut-Thibaut, Aurélie ; Kucharczak, Jérôme ; Savina, Ariel ; Salles, Gilles ; Aouacheria, Abdel

Leukemia research, 2017-04, Vol.55 (2), p.41-48 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein
Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein
Material Type:
Artigo 		Adicionar ao Meu Espaço

Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein

Bates, John T ; Keefer, Christopher J ; Slaughter, James C ; Kulp, Daniel W ; Schief, William R ; Crowe, James E

Virology (New York, N.Y.), 2014-04, Vol.454, p.139-144 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (23.953)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (24.155)
  2. Anais de Congresso  (4)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (1.673)
  2. 1988Até1996  (4.160)
  3. 1997Até2005  (5.970)
  4. 2006Até2015  (10.424)
  5. Após 2015  (1.933)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (24.143)
  2. Japonês  (3.039)
  3. Espanhol  (24)
  4. Francês  (7)
  5. Português  (6)
  6. Russo  (6)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.